Literature DB >> 21324237

What we have learned about electroconvulsive therapy and its relevance for the practising psychiatrist.

Pascal Sienaert1.   

Abstract

In this narrative review, the current knowledge base on the efficacy and the practice of electroconvulsive therapy (ECT) is reviewed, and its relevance for the practising psychiatrist is appreciated. In the past decade, several large-scale studies have confirmed the significant superiority of ECT in the treatment of severe and refractory psychiatric conditions, such as major depressive disorder and bipolar disorder. However, the efficacy of ECT is not reflected in current treatment algorithms, where ECT is often reserved as a last resort. However, clinical characteristics, such as the presence of psychotic symptoms, suicidality, or catatonic signs, should prompt the clinician to consider ECT earlier in the treatment course. ECT is a safe procedure, without absolute contraindications for its use. Nevertheless, patients' fears and complaints should be acknowledged, and patients should be adequately informed about expected benefits and possible risks, such as memory problems, that are generally transient. Research focusing on further minimizing memory problems, while maintaining a superior efficacy, is ongoing. Adequate continuation treatment, either pharmacotherapy or continuation ECT, after a successful ECT course is of vital importance to maintain the benefits achieved and should be the focus of future research.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21324237     DOI: 10.1177/070674371105600103

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN: 0706-7437            Impact factor:   4.356


  6 in total

Review 1.  Treatment of depression in older adults.

Authors:  Cássio M C Bottino; Ricardo Barcelos-Ferreira; Salma R I Ribeiz
Journal:  Curr Psychiatry Rep       Date:  2012-08       Impact factor: 5.285

2.  I'm shocked: informed consent in ECT and the phenomenological-self.

Authors:  Patrick Seniuk
Journal:  Life Sci Soc Policy       Date:  2018-02-13

3.  What is the process by which a decision to administer electroconvulsive therapy (ECT) or not is made? A grounded theory informed study of the multi-disciplinary professionals involved.

Authors:  Anna Duxbury; Ian Smith; Bethan Mair-Edwards; Gerry Bennison; Kerry Irving; Suzanne Hodge; Ian Anderson; Stephen Weatherhead
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2018-06-08       Impact factor: 4.328

4.  Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study.

Authors:  Michael C Mithoefer; Mark T Wagner; Ann T Mithoefer; Lisa Jerome; Scott F Martin; Berra Yazar-Klosinski; Yvonne Michel; Timothy D Brewerton; Rick Doblin
Journal:  J Psychopharmacol       Date:  2012-11-20       Impact factor: 4.153

5.  Medication management during electroconvulsant therapy.

Authors:  Monica Zolezzi
Journal:  Neuropsychiatr Dis Treat       Date:  2016-04-19       Impact factor: 2.570

Review 6.  Lateral Habenula Gone Awry in Depression: Bridging Cellular Adaptations With Therapeutics.

Authors:  Alvaro Nuno-Perez; Anna Tchenio; Manuel Mameli; Salvatore Lecca
Journal:  Front Neurosci       Date:  2018-07-23       Impact factor: 4.677

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.